Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

Novel method identified protein degraders that target Pin1, a protein involved in pancreatic cancer development.

Lonza offers customers a fully integrated solution, spanning design and lead molecule generation, including Synaffix ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

Studies suggest the cell is more interconnected than previously thought, opening up "exciting possibilities for science and medicine." ...

It might be possible for people in the future to consume BHB-Phe to drive weight loss without restricting carbohydrates in their diet.

Regular activity not only strengthens muscles but can bolster our bones, blood vessels, and immune system. MIT engineers have now found that exercise can also have benefits at the level of individual ...

Scale Bio names winning projects for the 100M cell challenge across diverse applications, from global health initiatives to ...

National Institutes of Health (NIH) scientists and collaborators say they have discovered a new way in which RAS genes, ...

At ASHG, Seer showcased its Proteograph product suite which it claims delivers proteomic insights that complement and ...

A trio of stock analysts this week examined the likely impacts on biopharma from Donald Trump’s election victory and ...

Customers will also share data from studies using the technologies including an effort to investigate protein biomarkers for ...